Head Laboratory Glycomedicine, IBYME and Professor of Immunology, University of Buenos Aires
Instituto de Biología y Medicina Experimental
Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina
Gabriel Rabinovich is Director of the Laboratory of Glycomedicine at the Institute of Biology and Experimental Medicine, Senior Investigator of the Argentinean National Research Council and Professor of Immunology at the Faculty of Exact and Natural Sciences, University of Buenos Aires. Among several recognitions, he has been distinguished as Member of the US National Academy of Science (NAS), European Molecular Biology Organization (EMBO), Latin American Academy of Science, World Academy of Science (TWAS) and Argentinean Academy of Sciences. His work was recognized with several awards including the Karl Meyer (USA), TWAS, Guggenheim (USA), Outstanding Investigator of the Nation (Argentina), Bunge Born and Konex Diamond (Argentina) awards. He has published 325 articles, including papers in high profile journals and filled 11 patents of his work. He serves as Associate Editor or member of the editorial board of several journals. Together with his group, he demonstrated that galectins can translate glycan-encoded information into regulatory programs that control inflammation, suppress autoimmune pathology and allow cancer cells to evade immune responses and promote angiogenesis. His findings opened new therapeutic possibilities in cancer and autoimmune inflammation. He recently co-founded Galtec, a Startup biotech aimed at translating galectin-based discoveries into new therapies. Gabriel has mentored 29 doctoral students and 27 post-doctoral fellows, delivered 450 lectures, organized international meetings and has done an extensive work in promoting the advance of immunology and glycosciences all over the world. He received financial support from several national and international agencies. He is Director of the Glycoimmunology FOCIS Center of Excellence.
Disclosure information not submitted.
Reprogramming the Tumor-immune Microenvironment by Targeting the Galectin-glycan Axis
Friday, June 21, 2024
2:00 PM – 2:25 PM PT
